Most active investors · Jan 1, 2026 – Oct 25, 2026
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 25, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
Superluminal Medicines $60M Series BSteward $5M Pre-SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
HiddenLayer $100M Series BNucleus Security $20M Series CDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
FlyAkeed SAR 94.3M Growth fundingVennre $9.6M Pre-Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
DocPharma $2M Pre-Series A1Buy.AI $3.9M SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Wonderful $550M Series CGenLogs $60M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Upwind Security ~$300M FundingHelion $465M Series GDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
iPremom €15M SeedATMOS Space Cargo €25.7M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
HyImpulse >€50M Series A extensionWasteSide >€700K SeedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
Thyme Care >$125M Series EScan.com $220M Series C equity + debt facilitiesDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Nexedge Capital $20M First funding roundRiver Mobility $120M Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
HyImpulse >€50M Series A extensionISPTech €5.5M SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Thyme Care >$125M Series EConnie Health $40M Series BDetails
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Capacity >$54M Series ECapacity Undisclosed StrategicDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
HyImpulse >€50M Series A extensionSweGaN $14M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Typewriter Therapeutics $56M Series ASift Biosciences $3.7M Pre-SeedDetails
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tripo AI ~$445M Series BShenkong Zhixu Undisclosed AngelDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Reapit >£20M Growth investmentExxat Undisclosed Strategic“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.